(Q39190483)

English

Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN).

scientific article published on 28 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Benefits of a pharmacology antimalarial reference standard and proficiency testing program provided by the Worldwide Antimalarial Resistance Network (WWARN). (English)

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

0 references

1 reference

based on heuristic

inferred from title

Philippe J. Guerin

4

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

object named as

Joel Tarning

7

0 references

Nicholas John White

6

object named as

Nicholas J White

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

author name string

Chris Lourens

1

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Niklas Lindegardh

2

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Karen I Barnes

3

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Carol H Sibley

5

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

language of work or name

0 references

publication date

28 April 2014

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

58

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

3889-3894

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068537

10 September 2017

Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068537

10 September 2017

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068537

10 September 2017

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4068537

10 September 2017

Method validation in the bioanalytical laboratory

1 reference

https://pubmed.ncbi.nlm.nih.gov/24777099

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.02362-14

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39190483&oldid=1773832152"